
Sign up to save your podcasts
Or
This week on BioTech Nation, Dr. Cory Nicholas, Co-Founder and CEO of Neurona Therapeutics, discusses their groundbreaking success in treating drug-resistant epilepsy. With a single, targeted delivery of lab-grown brain cells, Neurona is offering not just symptom control but the possibility of long-term seizure relief. This is Part 1 of a two-part series exploring the future of regenerative medicine in neurology.
4.1
2929 ratings
This week on BioTech Nation, Dr. Cory Nicholas, Co-Founder and CEO of Neurona Therapeutics, discusses their groundbreaking success in treating drug-resistant epilepsy. With a single, targeted delivery of lab-grown brain cells, Neurona is offering not just symptom control but the possibility of long-term seizure relief. This is Part 1 of a two-part series exploring the future of regenerative medicine in neurology.
6,133 Listeners
4,238 Listeners
32,299 Listeners
3,481 Listeners
22,089 Listeners
2,174 Listeners
26,469 Listeners
3,369 Listeners
6,696 Listeners
9,272 Listeners
318 Listeners
29 Listeners
15,335 Listeners
3,365 Listeners
1,175 Listeners